A recent study has shown that one dose of Bavarian Nordic’s Jynneos vaccine was overall 58% effective at preventing mpox ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...

A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High ...

The WHO's interim guidance on social and behavioral research for the mpox response emphasizes the integration of ethical, ...

Bavarian Nordic vaccine, originally approved for smallpox, is safe and well tolerated in at-risk individuals, with one dose ...

A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

The Mpox virus is related to the original smallpox virus (Variola major). The EMA’s decision to approve Imvanex was based on laboratory data showing that the vaccine offers cross-protection.

The Mpox virus is related to the original smallpox virus (Variola major). The EMA’s decision to approve Imvanex was based on laboratory data showing that the vaccine offers cross-protection. Until now ...

recently presented data demonstrating that tecovirimat did not improve mpox resolution. The results from STOMP (Study of Tecovirimat for Mpox, also known as A5418) were shared as the oral ...